Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences
about
In Potential Stroke Patients on Warfarin, the International Normalized Ratio Predicts Ischemia.Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studies.Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerationsThe Future of Nanoparticle-Directed Venous Therapy.Anticoagulation Therapy and NOACs in Heart Failure.Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.Association between satisfaction with and adherence to warfarin therapy on the control of international normalized ratio: A hospital-based study in Saudi Arabia.The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist.Low Performance of a Clinical-Genetic Model in the Estimation of Time in Therapeutic Range in Acenocoumarol-Adherent Patients with Nonvalvular Atrial Fibrillation: The Quality of Anticoagulation Challenge
P2860
Q38627354-CB8E58AA-AEC8-4E3D-8689-49E472E054FBQ38655829-65D09361-F8EF-443E-AC99-622515B2294CQ38707885-B35F9B0B-1293-4659-A77C-94F37FA51206Q38749932-DF4BB1C2-93FC-4F6E-A69A-202A41980F60Q39148821-0092B988-55B1-443A-A7E7-3CA7D0936A67Q45974877-7B517795-706D-4734-A51F-4F6064B450C0Q48510673-BC829F6C-C79E-4490-A430-46F75EF6F85AQ51744592-80109D3C-5C9D-4A05-8989-61E23ABAF2EBQ58695455-F3F2A721-DC48-4782-A120-E9840B6E0442
P2860
Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Vitamin K antagonist use: evid ...... ge and subsequent consequences
@ast
Vitamin K antagonist use: evid ...... ge and subsequent consequences
@en
Vitamin K antagonist use: evid ...... ge and subsequent consequences
@nl
type
label
Vitamin K antagonist use: evid ...... ge and subsequent consequences
@ast
Vitamin K antagonist use: evid ...... ge and subsequent consequences
@en
Vitamin K antagonist use: evid ...... ge and subsequent consequences
@nl
prefLabel
Vitamin K antagonist use: evid ...... ge and subsequent consequences
@ast
Vitamin K antagonist use: evid ...... ge and subsequent consequences
@en
Vitamin K antagonist use: evid ...... ge and subsequent consequences
@nl
P2093
P2860
P3181
P1433
P1476
Vitamin K antagonist use: evid ...... ge and subsequent consequences
@en
P2093
C Michael White
Craig I Coleman
Elizabeth S Mearns
Jeff R Schein
Jeffrey Kluger
Winnie W Nelson
P2860
P2888
P3181
P356
10.1186/S12959-016-0088-Y
P407
P577
2016-01-01T00:00:00Z
P6179
1000621460